Navigation Links
Cell Saver® 5 System

ProductsCell Saver® 5 System
Company Haemonetics
Item Cell Saver® 5 System
Features 
  • The latest in microprocessor and sensor technologies
  • Full automation, with the option of switching to manual operation at any time
  • A compact, portable design, making it easy to transport
  • Advanced optics that assure consistent processing and a high-quality blood product
  • Bowl technology that provides fast processing and a consistent, high-quality blood product
  • Flexibility, with 225ml, 125ml, and 70ml bowls that expand processing options
  • Sequestering capabilities that enable semiautomatic collection of platelet-rich plasma
  • Built-in safety features that protect the patient's blood and the machine operator
  • Excellent service and support, from a Company that recently won the Omega Northface Award for service excellence for the second year in a row
Description Haemonetics invented surgical blood salvage nearly thirty years ago and has been an innovator in the field ever since. The Cell Saver autologous blood recovery systems are used in operating room procedures in which there is rapid bleeding or high-volume blood loss.
Info Haemonetics
Customer Service: (800) 225-5242
Web site: http://www.haemonetics.com/site/content/home.asp

Related medicine products :

1. Silicone Oil Cannula System - 20 Gauge
2. Silicone Oil Cannula System - 19 Gauge
3. SuperVu Galilean System
4. KOWA nonmyd 7 / VK-2 Digital Imaging System
5. KOWA nonmyd a-D / VK-2 Digital Imaging System
6. Refraction System RT-2100
7. Odyssey Phacoemulsification System
8. SIStem Phacoemulsification System
9. Precisionist Phacoemulsification System
10. Photon Laser Phacoemulsification System
11. Phaco-Emulsification System
Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube...
Reliavac 100cc evacuators offer a more constant suction profile than silicone evacuators. 100cc capacity is easy for patient to carry. Bottom emptying port reduces chance of contamination....
Used with T-tubes to collect drainage after cholecystectomy. Includes T-tube adapter and two adjustable latex rubber belts....
Used following hysterectomy procedure. Often attached to Bard bile bag....
Medicine Products:
(Date:4/26/2015)... Lauderdale, FL (PRWEB) April 26, 2015 ... 1,200 pieces of medical equipment from hospitals, surgery centers ... types of equipment will be sold including radiology, surgery, ... The live auction will take place Tuesday, April 28th ... Fort Lauderdale warehouse located at 5025 North Hiatus Rd., ...
(Date:4/26/2015)... In an article published last month ... head-neck biomechanics occurring during the use of handheld electronic devices ... determine that use of a tablet increases mechanical demand on ... - more than when the neck is in a neutral ... but pointing out the potential hazards of overuse of mobile ...
(Date:4/26/2015)... April 26, 2015 MidSouth Pain ... throughout the Southeast. MidSouth Pain Treatment Center is a ... Cordova, Southaven, Oxford and Jackson, two ambulatory surgery centers ... the Southaven and Cordova locations. , Dr. Michael ... went into medicine to help people, and when I ...
(Date:4/25/2015)... Avid Collector Andrew Hawley from Vintage Rock ... Coliseum concert posters. The concert was held on 12 ... American Tour. , According to Hawley, “The poster ... Maryland. This poster blank was used to advertise the ... uses garish lettering and colors on this boxing style ...
(Date:4/25/2015)... Jersey (PRWEB) April 25, 2015 In ... aged twelve and above needed treatment for an ... to the Substance Abuse and Mental Health Services Administration’s ... 2011). Beyond these alarming numbers are harrowing stories of ... substance abuse . David H. Kerr , ...
Breaking Medicine News(10 mins):Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
... News) -- People affected by epilepsy are nearly eight ... schizophrenia, and those with schizophrenia are also six times ... not schizophrenic, a new study suggests. Researchers in ... may be due to genetic, environmental or neurobiological causes. ...
... the Mining Microbial Genomes for Novel Antibiotics research theme ... a recipient of the 2011 National Institutes of Health ... from some of the nation,s most promising new scientists. ... of five years, supports young investigators who have proposed ...
... Talking with doctors about cancer and cancer treatments can feel ... often need help to understand their treatment options, and the ... making life and death decisions that may affect their survival ... Cancer treatments and tests can be serious. Patients need to ...
... DURHAM, N.C. An analysis of more than 30,000 cancer ... complication than doctors may realize, causing additional hospitalizations and driving ... by a Duke Cancer Institute researcher. The study, which ... Cancer Congress in Stockholm, found that as many as one ...
... based method of family planning developed by researchers from ... so effectively meets the needs of users that they continue ... finds that women who follow the Standard Days Method, are ... effectively. Results of the large, multi-country study of 1659 women ...
... new type of nanoparticle developed in the laboratories at the ... delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, ... their finding in the Sept. 14, 2011 issue of ... laboratory studies, Lin and colleagues developed and tested a new ...
Cached Medicine News:Health News:Researchers Find Link Between Epilepsy, Schizophrenia Risk 2Health News:10 ways to make better decisions about cancer care 2Health News:10 ways to make better decisions about cancer care 3Health News:Costly blood clots more common than expected among cancer patients 2Health News:Long-term effectiveness of new family planning method shown in study 2Health News:UNC scientist proves potential of new nanoparticle design for cancer therapy 2
(Date:4/24/2015)... BARCELONA, Spain , April 24, 2015  Elekta ... popular Monaco® treatment planning system , enabling European ... that supports major treatment techniques including advanced 3D planning, ... single system. Monaco ... enhancements, as well improved workflow efficiency. Advancements in 3D ...
(Date:4/23/2015)... NORTH CHICAGO, Ill. , April 24, 2015 /PRNewswire/ ... U.S. Food and Drug Administration (FDA) has accepted its ... the company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ... is for the treatment of adults with chronic genotype ... AbbVie,s regimen is the first all-oral, interferon-free therapy being ...
(Date:4/23/2015)...  ResMed Inc. (NYSE: RMD ) today announced ... for the quarter was $422.5 million, a 6 percent ... (a 13 percent increase on a constant currency basis).  ... percent compared to the quarter ended March 31, 2014.  ... an increase of 2 percent compared to the quarter ...
Breaking Medicine Technology:Elekta CE marks for Monaco v5.10 treatment planning system 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13